- Home
- NPV vs OSUR Comparison
NPV vs OSUR Comparison
Compare NPV & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPV
- OSUR
- Stock Information
- Founded
- NPV 1993
- OSUR 2000
- Country
- NPV United States
- OSUR United States
- Employees
- NPV N/A
- OSUR N/A
- Industry
- NPV Investment Managers
- OSUR Medical/Dental Instruments
- Sector
- NPV Finance
- OSUR Health Care
- Exchange
- NPV Nasdaq
- OSUR Nasdaq
- Market Cap
- NPV 241.2M
- OSUR 289.4M
- IPO Year
- NPV N/A
- OSUR 1986
- Fundamental
- Price
- NPV $13.17
- OSUR $3.92
- Analyst Decision
- NPV
- OSUR Buy
- Analyst Count
- NPV 0
- OSUR 3
- Target Price
- NPV N/A
- OSUR $6.67
- AVG Volume (30 Days)
- NPV 38.9K
- OSUR 896.3K
- Earning Date
- NPV 01-01-0001
- OSUR 11-06-2024
- Dividend Yield
- NPV 3.90%
- OSUR N/A
- EPS Growth
- NPV N/A
- OSUR N/A
- EPS
- NPV N/A
- OSUR 0.15
- Revenue
- NPV N/A
- OSUR $224,263,000.00
- Revenue This Year
- NPV N/A
- OSUR N/A
- Revenue Next Year
- NPV N/A
- OSUR N/A
- P/E Ratio
- NPV N/A
- OSUR $25.79
- Revenue Growth
- NPV N/A
- OSUR N/A
- 52 Week Low
- NPV $8.92
- OSUR $3.72
- 52 Week High
- NPV $11.55
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- NPV 41.83
- OSUR 47.78
- Support Level
- NPV $13.30
- OSUR $3.83
- Resistance Level
- NPV $13.72
- OSUR $4.14
- Average True Range (ATR)
- NPV 0.15
- OSUR 0.17
- MACD
- NPV -0.05
- OSUR 0.01
- Stochastic Oscillator
- NPV 0.00
- OSUR 36.05
About NPV Nuveen Virginia Quality Municipal Income Fund
Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.